What are the contraindications to amiodarone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications to Amiodarone

Amiodarone is absolutely contraindicated in patients with cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block without a functioning pacemaker, as well as in those with known hypersensitivity to amiodarone or iodine. 1

Absolute Contraindications

The following conditions represent absolute contraindications where amiodarone must not be used:

  • Cardiogenic shock 1
  • Marked sinus bradycardia 1
  • Second- or third-degree AV block without a functioning pacemaker 2, 1
  • Known hypersensitivity to amiodarone, its components, or iodine 1
  • Severe sinus node dysfunction 3
  • Heart transplant patients 3

Critical Relative Contraindications

These conditions require extreme caution and often represent practical contraindications in most clinical scenarios:

Cardiovascular Conditions

  • Pre-excitation syndromes (e.g., WPW) with atrial fibrillation - IV amiodarone may increase ventricular response and precipitate ventricular fibrillation 3
  • Bradycardia (heart rate <60 bpm) - particularly concerning as amiodarone causes bradycardia in 1-3% of patients 3
  • Hypotension (systolic BP <100 mmHg) - IV amiodarone causes hypotension in 16% of patients 3
  • Moderate to severe left ventricular failure - requires careful assessment 3

Pulmonary Conditions

  • Pre-existing inflammatory lung disease - significantly increases risk of potentially fatal pulmonary toxicity 3
  • Severe chronic obstructive pulmonary disease 3
  • History of asthma 3

Hepatic and Metabolic Conditions

  • Severe hepatic dysfunction - amiodarone causes hepatotoxicity at 0.6% annually; discontinue if liver enzymes exceed 3x normal 2, 3
  • Hyperthyroidism - amiodarone contains significant iodine and can worsen thyroid dysfunction 3

Other High-Risk Conditions

  • Severe peripheral vascular disease 3
  • Insulin-dependent diabetes 3

Special Population Considerations

Pregnancy

  • Avoid in pregnancy, especially first trimester - risk of congenital malformations 3

Patients on Specific Medications

Amiodarone should not be used without expert consultation in patients taking:

  • Procainamide or other QT-prolonging medications 3
  • Dronedarone - contraindicated in permanent atrial fibrillation due to increased stroke, MI, and cardiovascular death risk 3

Drug Interaction Warnings Requiring Dose Adjustments

When amiodarone must be used with these medications, mandatory dose reductions are required:

  • Warfarin: reduce dose by 50% and monitor INR at least weekly for first 6 weeks 3
  • Digoxin: reduce dose by 50% due to significant elevation of digoxin levels 3, 4
  • Statins: use with extreme caution due to increased myopathy/rhabdomyolysis risk 3

Mandatory Pre-Treatment Assessment

Before initiating amiodarone, the following baseline evaluations are required to identify contraindications 2, 3:

  • Complete history focusing on congestive heart failure, arrhythmia symptoms, and concomitant medications
  • Chest radiograph - to establish baseline for pulmonary toxicity monitoring
  • Thyroid studies (TSH, free T4) - to identify pre-existing thyroid dysfunction
  • Liver transaminase levels - to establish baseline hepatic function
  • Pulmonary function tests including DLCO - critical for detecting early pulmonary toxicity
  • ECG - to document baseline QT interval and conduction abnormalities
  • Ophthalmologic examination - if pre-existing visual impairment present
  • Digoxin level, PT/INR - when applicable

Common Pitfalls to Avoid

  • Do not overlook subclinical sinus node dysfunction - amiodarone will unmask and worsen this condition 3
  • Do not assume QT prolongation alone is a contraindication - while amiodarone prolongs QT in nearly all patients, torsades de pointes is rare (<1% annually) compared to other antiarrhythmics 2, 3
  • Do not use in patients with uncorrected hypokalemia or hypomagnesemia - these electrolyte abnormalities significantly increase proarrhythmic risk 3
  • Do not initiate without establishing a monitoring plan - pulmonary toxicity can develop rapidly without antecedent abnormalities 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Contraindications and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adverse reactions during treatment with amiodarone hydrochloride.

British medical journal (Clinical research ed.), 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.